Actively Recruiting

All Genders
NCT06548152

AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database

Led by AstraZeneca · Updated on 2026-04-16

120

Participants Needed

1

Research Sites

87 weeks

Total Duration

On this page

Sponsors

A

AstraZeneca

Lead Sponsor

H

Hospitalidee

Collaborating Sponsor

AI-Summary

What this Trial Is About

QoL is often not assessed in real-world studies; hence, there is limited understanding about the real-world QoL of patients diagnosed with CLL. Besides, studies evaluating QoL have largely focused on comparing treated and untreated populations. In particular, QoL of patients treated with acalabrutinib has not been evaluated in a real-life setting. The aim of this study is to describe the QoL of CLL patients treated with acalabrutinib between the treatment initiation and twelve months after, in a real-life setting.

CONDITIONS

Official Title

AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient enrolled in the PLATON database
  • Patient 18 years old or older
  • Treatment naive CLL patient treated with acalabrutinib in a real-life setting, either as monotherapy or with obinutuzumab
  • Patient does not object to reuse of health data collected in the PLATON study for research purposes
  • Patients who started acalabrutinib but discontinued before 12 months are included
Not Eligible

You will not qualify if you...

  • Pregnant women
  • Patients under protection of justice
  • Patients over 18 years unable to express their non-opposition
  • Patients with prior CLL treatments

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Research Site

Saint-Affrique, France

Actively Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here